Showing results (131-140 of 346) with videos related to

Sort By:
Pageof 35
Antimicrobial Agents and Chemotherapy|May 20, 2020
Antimicrobial Susceptibility and Cross-Resistance Patterns among Common Complicated Urinary Tract Infections in U.S. Hospitals, 2013 to 2018Marya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
Open Forum Infectious Diseases|January 17, 2022
Descriptive Epidemiology and Outcomes of Hospitalizations With Complicated Urinary Tract Infections in the United States, 2018Marya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
Chest|November 30, 2020
A Minority of Patients on Mechanical Ventilation Consume Disproportionate Resources: A Retrospective Cohort StudyMarya D Zilberberg, Brian H Nathanson, Judy Ways, et al.
Critical Care Medicine|January 23, 2008
Prolonged acute mechanical ventilation, hospital resource utilization, and mortality in the United StatesMarya D Zilberberg, Rose S Luippold, Sandra Sulsky, et al.
Antimicrobial Agents and Chemotherapy|July 12, 2017
Comparison of Plasma and Intrapulmonary Concentrations of Nafithromycin (WCK 4873) in Healthy Adult SubjectsKeith A Rodvold, Mark H Gotfried, Rakesh Chugh, et al.
Pharmacotherapy|May 28, 2004
Sex-related differences in the pharmacokinetics of once-daily saquinavir soft-gelatin capsules boosted with low-dose ritonavir in patients infected with human immunodeficiency virus type 1Manjunath P Pai, Christopher A Schriever, Mariela Diaz-Linares, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2005
Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic modelElizabeth D Hermsen, Laurie B Hovde, Kelly A Sprandel, et al.
Epilepsia|September 3, 2015
Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteersLindy L Bancke, Heather A Dworak, Keith A Rodvold, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
Variability in telavancin cross-reactivity among vancomycin immunoassaysKevin W McConeghy, Siyun Liao, Douglas Clark, et al.
Antimicrobial Agents and Chemotherapy|October 1, 2024
Intrapulmonary pharmacokinetics of SPR719 following oral administration of SPR720 to healthy volunteersKeith A Rodvold, Mark H Gotfried, Xilla T Ussery, et al.
Pageof 35